Major Semiconductor Stocks Scare Off Short Sellers
The June 29 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
All Work
Chris Lange
Short Sellers Back Off Major Biotechs
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a down day for the broad U.S. markets, with all the major averages giving back some of their gains from earlier in the week. Crude oil was massively down backing off its…
Akcea Therapeutics Jumps on European Marketing Approval
Akcea Therapeutics shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals that they had received a marketing authorization approval from the European Commission.
More Charges Come to Light in FitBit Fraud
The SEC has filed fraud charges against a second defendant in connection with a scheme to manipulate the price of Fitbit securities through false regulatory filings.
Robo Taxis on the Way With New Nvidia Partnership
Nvidia shares dipped on Wednesday after the firm announced that it would be joining forces with Daimler and Bosch to bring fully automated and driverless vehicles to city streets.
BioCryst Shareholders Back Out of Idera Merger
Idera Pharmaceuticals shares crumbled on Wednesday after BioCryst Pharmaceuticals announced that it terminated the merger agreement.
AbbVie Slumps on Late-Stage Lymphoma Trial
AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.
CEO Exits Rising Over the Summer
In June 2018, 90 CEOs left their jobs, according to the latest report from outplacement firm Challenger, Gray & Christmas.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a relatively positive day for the broad U.S. markets, with all the major averages edging up. Crude oil was again positive on the day but only marginally. The S&P 500 sectors were…
New Lowe’s CEO Wastes No Time Restructuring Upper Level Management
Lowe’s shares saw a nice bounce on Tuesday after the company announced that it would be restructuring its upper level management team.
Replimune Closes in on IPO
Biotechnology company Replimune intends to price more than 6 million shares in an initial public offering valued up to more than $123 million.
Nordstrom Sales Projections Not Enough for Investors
Nordstrom shares pulled back on Tuesday after the department store chain announced its sales projections for the next five years. Ultimately its targets were not up to par with what Wall Street had in…
Pepsi Cheers Q2 Earnings
PepsiCo reported better-than-expected second-quarter financial results before the markets opened on Tuesday.
Whole Foods Rolls Out the Deals for Amazon Prime Day
Whole Foods is offering Prime members a $10 credit to use during the 36-hour Prime Day sale, and that's just one of the deals.
Celgene and Acceleron Pharma Win Again in Late-Stage Trial
Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage study in adults with transfusion-dependent beta-thalassemia.
7 Big Companies Expected to Beat Earnings
The new earnings season will be driven by some of the biggest companies in the United States, but they have to hit their targets first if the markets want to keep up their momentum.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a solid day for the broad U.S. markets, kicking off the week on a very positive note. Crude oil was fairly volatile on the day, but ultimately ended up positive. The S&P…
AFG Holdings Announces Potential Pricing for IPO
Original equipment manufacturer AFG intends to sell more than 18 million shares in an initial public offering valued up to more than $376 million.
Axovant Wins With Key Licensing Agreement
Axovant Sciences shares saw a handy gain on Monday after the company announced that it has licensed exclusive global rights to an investigational gene therapy program from Benitec Biopharma.